DrugPatentWatch Database Preview
Daiichi Sankyo Company Profile
Email this page to a colleague
What is the competitive landscape for DAIICHI SANKYO, and what generic alternatives to DAIICHI SANKYO drugs are available?
DAIICHI SANKYO has thirteen approved drugs.
There are eighteen US patents protecting DAIICHI SANKYO drugs.
There are two hundred and ninety-two patent family members on DAIICHI SANKYO drugs in forty-five countries and fifty-two supplementary protection certificates in sixteen countries.
Summary for Daiichi Sankyo
| International Patents: | 292 |
| US Patents: | 18 |
| Tradenames: | 10 |
| Ingredients: | 10 |
| NDAs: | 13 |
| Patent Litigation for Daiichi Sankyo: | See patent lawsuits for Daiichi Sankyo |
| PTAB Cases with Daiichi Sankyo as patent owner: | See PTAB cases with Daiichi Sankyo as patent owner |
Drugs and US Patents for Daiichi Sankyo
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Daiichi Sankyo Inc | TURALIO | pexidartinib hydrochloride | CAPSULE;ORAL | 211810-001 | Aug 2, 2019 | RX | Yes | Yes | 9,802,932 | ⤷ Try it Free | Y | ⤷ Try it Free | |||
| Daiichi Sankyo | WELCHOL | colesevelam hydrochloride | FOR SUSPENSION;ORAL | 022362-002 | Oct 2, 2009 | AB | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | ||||
| Daiichi Sankyo | BENICAR | olmesartan medoxomil | TABLET;ORAL | 021286-003 | Apr 25, 2002 | AB | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | ||||
| Daiichi Sankyo | TRIBENZOR | amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil | TABLET;ORAL | 200175-004 | Jul 23, 2010 | AB | RX | Yes | No | ⤷ Try it Free | ⤷ Try it Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Daiichi Sankyo
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Daiichi Sankyo | WELCHOL | colesevelam hydrochloride | FOR SUSPENSION;ORAL | 022362-002 | Oct 2, 2009 | 7,101,960*PED | ⤷ Try it Free |
| Daiichi Sankyo | WELCHOL | colesevelam hydrochloride | FOR SUSPENSION;ORAL | 022362-001 | Oct 2, 2009 | 5,917,007*PED | ⤷ Try it Free |
| Daiichi Sankyo | WELCHOL | colesevelam hydrochloride | FOR SUSPENSION;ORAL | 022362-001 | Oct 2, 2009 | 6,784,254*PED | ⤷ Try it Free |
| Daiichi Sankyo | WELCHOL | colesevelam hydrochloride | TABLET;ORAL | 021176-001 | May 26, 2000 | 5,607,669*PED | ⤷ Try it Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for DAIICHI SANKYO drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 5 mg and 10 mg | ➤ Subscribe | 2013-07-10 |
| ➤ Subscribe | Tablets | 625 mg | ➤ Subscribe | 2009-07-01 |
| ➤ Subscribe | Tablets | 5 mg/20 mg and 10 mg/40 mg | ➤ Subscribe | 2008-02-11 |
| ➤ Subscribe | Tablets | 5 mg, 20 mg and 40 mg | ➤ Subscribe | 2006-04-25 |
| ➤ Subscribe | Tablets | 40 mg/12.5 mg and 40 mg/25 mL | ➤ Subscribe | 2007-02-15 |
| ➤ Subscribe | Tablets | 15 mg, 30 mg, 60 mg and 100 mg | ➤ Subscribe | 2019-01-28 |
| ➤ Subscribe | Tablets | 15 mg, 30 mg and 60 mg | ➤ Subscribe | 2019-01-28 |
| ➤ Subscribe | Powder for Oral Suspension | 1.875 g/Packet and 3.75 g/Packet | ➤ Subscribe | 2010-04-09 |
| ➤ Subscribe | Tablets | 10 mg/20 mg and 5 mg/40 mg | ➤ Subscribe | 2008-03-31 |
| ➤ Subscribe | Tablets | 20 mg/12.5 mg | ➤ Subscribe | 2007-05-11 |
| ➤ Subscribe | Capsules | 30 mg | ➤ Subscribe | 2009-02-27 |
International Patents for Daiichi Sankyo Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2002257147 | ⤷ Try it Free |
| Hong Kong | 1058620 | ⤷ Try it Free |
| Slovenia | 2140867 | ⤷ Try it Free |
| Spain | 2644803 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Daiichi Sankyo Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0503785 | 20/2009 | Austria | ⤷ Try it Free | PRODUCT NAME: KOMBINATION VON OLMESARTAN MEDOXOMIL, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH AKZEPTABLEN SALZES, MIT AMLODIPINBESILAT; NAT. REGISTRATION NO/DATE: 1-27894, 1-27895, 1-27896 20081217; FIRST REGISTRATION: NL 100989, 100990, 100991 20080819 |
| 0502314 | C300478 | Netherlands | ⤷ Try it Free | PRODUCT NAME: TELMISARTAN, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, EN AMLODIPINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER AMLODIPINEBESILAAT; REGISTRATION NO/DATE: EU/1/10/648/001-028 20101007 |
| 0503785 | SPC/GB03/024 | United Kingdom | ⤷ Try it Free | PRODUCT NAME: OLMESARTAN MEDOXOMIL, OPTIONALLY IN THE FORM OF A PHAMACEUTICALLY ACCEPTABLE SALT; REGISTERED: DE 50202.00.00 20020813; DE 50202.01.00 20020813; DE 50202.02.00 20020813; DE 50205.00.00 20020813; DE 50205.01.00 20020813; DE 50205.02.00 20020813; UK PL 08265/0015 20030522; UK PL 08265/0016 20030522; UK PL08265/0017 20030522 |
| 1915993 | C300625 | Netherlands | ⤷ Try it Free | PRODUCT NAME: COMBINATIE BEVATTENDE ALISKIREN, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, EN AMLODIPINE, OF EEN FARMACEUATISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/11/686/001-056 20110414 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
